Identification of potential molecular biomarkers for response of soft tissue sarcoma to eribulin: Translational results of EORTC trial 62052

被引：0
|
作者：
Wozniak, Agnieszka
Wiemer, Erik A. C.
Burger, Herman
Allemeersch, Joke
van Eijsden, Rudy
Mathijssen, Ron H. J.
Sleijfer, Stefan
Smid, Marcel
Floris, Giuseppe
Marreaud, Sandrine
Nzokirantevye, Axelle
Sciot, Raf
Schoffski, Patrick
机构：
[1] Katholieke Univ Leuven, Expt Oncol Lab, Leuven, Belgium
[2] Katholieke Univ Leuven, Dept Gen Med Oncol, Leuven, Belgium
[3] Univ Hosp, Leuven, Belgium
[4] Erasmus MC, Daniel den Hoed Canc Ctr, Rotterdam, Netherlands
[5] VIB, Nucle Core, Leuven, Belgium
[6] Erasmus MC, Dept Med Oncol, Rotterdam, Netherlands
[7] Erasmus MC, Dept Med Oncol & Canc Genom Netherlands, Rotterdam, Netherlands
[8] Katholieke Univ Leuven, Dept Pathol, Leuven, Belgium
[9] EORTC, Brussels, Belgium
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10573
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Identification of microRNA biomarkers for response of advanced soft tissue sarcomas to eribulin: Translational results of the EORTC 62052 trial
    Wiemer, Erik A. C.
    Wozniak, Agnieszka
    Burger, Herman
    Smid, Marcel
    Floris, Giuseppe
    Nzokirantevye, Axelle
    Sciot, Raf
    Sleijfer, Stefan
    Schoffski, Patrick
    [J]. EUROPEAN JOURNAL OF CANCER, 2017, 75 : 33 - 40
  • [2] Eribulin mesylate (E7389) in patients with leiomyosarcoma (LMS) and other (OTH) subtypes of soft tissue sarcoma (STS): a Phase II study from the European Organisation for Research and Treatment of Cancer - Soft Tissue and Bone Sarcoma Group (EORTC 62052)
    Schoeffski, P.
    Hartmann, J. T.
    Hohenberger, P.
    Krarup-Hansen, A.
    Wanders, J.
    Hayward, C.
    Druyts, D.
    Van Glabbeke, M.
    Sciot, R.
    Blay, J. Y.
    [J]. EJC SUPPLEMENTS, 2009, 7 (02): : 591 - 591
  • [3] Potential molecular biomarkers of response to eribulin in patients with leiomyosarcoma
    Wozniak, Agnieszka
    Boecks, Bram
    Modave, Elodie
    Weaver, Amy
    Lambrechts, Diether
    Littlefield, Bruce A.
    Schoffski, Patrick
    [J]. CANCER RESEARCH, 2020, 80 (16)
  • [4] EORTC PROTOCOL FOR THERAPY OF METASTATIC SOFT-TISSUE SARCOMA, A RANDOMIZED TRIAL
    PINEDO, HM
    VENDRIK, CPJ
    STAQUET, M
    KENIS, Y
    SYLVESTER, R
    [J]. EUROPEAN JOURNAL OF CANCER, 1977, 13 (07) : 765 - 771
  • [5] Activity of cribulin mesylate (E7389) in patients with soft tissue sarcoma (STS): Phase II studies of the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group (EORTC 62052).
    Schoffski, P.
    Ray-Coquard, I. L.
    Cioffi, A.
    Bin Bui, N.
    Bauer, S.
    Hartmann, J. T.
    Sciot, R.
    Wanders, J.
    Druyts, D.
    Hohenberger, P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [6] Exatecan in pretreated adult patients with advanced soft tissue sarcoma:: Results of a phase II -: Study of the EORTC Soft Tissue and Bone Sarcoma Group
    Reichardt, P.
    Nielsen, O. S.
    Bauer, S.
    Hartmann, J. T.
    Schoffski, P.
    Christensen, T. B.
    Pink, D.
    Daugaard, S.
    Marreaud, S.
    van Glabbeke, M.
    Blay, J. Y.
    [J]. EUROPEAN JOURNAL OF CANCER, 2007, 43 (06) : 1017 - 1022
  • [7] Preoperative Radiotherapy for retroperitoneal Soft Tissue Sarcoma: Results of the EORTC-STRASS-Study
    Kalisch, Ann-Kristin
    Dunst, Andreas
    Dunst, Juergen
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2021, 197 (05) : 455 - 457
  • [8] Soft Tissue Sarcoma: An Insight on Biomarkers at Molecular, Metabolic and Cellular Level
    Pillozzi, Serena
    Bernini, Andrea
    Palchetti, Ilaria
    Crociani, Olivia
    Antonuzzo, Lorenzo
    Campanacci, Domenico
    Scoccianti, Guido
    [J]. CANCERS, 2021, 13 (12)
  • [9] PHASE-II STUDY OF FOTEMUSTINE IN ADVANCED SOFT-TISSUE SARCOMAS - A TRIAL OF THE EORTC SOFT-TISSUE AND BONE SARCOMA GROUP
    KERBRAT, P
    SOMERS, R
    VERWEIJ, J
    CROWTHER, D
    TURSZ, T
    SANTORO, A
    STEWARD, WP
    LENTZ, MA
    VANGLABBEKE, M
    MOURIDSEN, HT
    [J]. EUROPEAN JOURNAL OF CANCER, 1993, 29A (01) : 143 - 144
  • [10] Interim results of a real-world observational study of eribulin in soft tissue sarcoma including rare subtypes
    Kobayashi, Eisuke
    Naito, Yoichi
    Asano, Naofumi
    Maejima, Aiko
    Endo, Makoto
    Takahashi, Shunji
    Megumi, Yasunori
    Kawai, Akira
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2019, 49 (10) : 938 - 946
12345